| Human Cytochrome P450 17A1 in complex with steroidal isonitrile inhibitor | | homo-2-mer | 28-503 | 100.0 | 2×HEM; 2×XPK; |
|
| Human Cytochrome P450 17A1 in complex with TOK-001 | | monomer | 30-504 | 100.0 | 1×HEM; 1×TOK; |
|
| Human Cytochrome P450 17A1 in complex with inhibitor: abiraterone C6 nitrile | | monomer | 30-504 | 100.0 | 1×HEM; 1×3NR; |
|
| Human Cytochrome P450 17A1 in complex with inhibitor: abiraterone C6 amide | | monomer | 30-504 | 100.0 | 1×HEM; 1×3NX; |
|
| Human steroidogenic cytochrome P450 17A1 with 3alphaOH-5alpha-abiraterone analog | | monomer | 31-504 | 100.0 | 1×HEM; 1×8QD; |
|
| Human Cytochrome P450 17A1 in complex with inhibitor: abiraterone C6 oxime | | monomer | 31-504 | 100.0 | 1×HEM; 1×3NQ; |
|
| Human steroidogenic cytochrome P450 17A1 with 3-keto-delta4-abiraterone analog | | monomer | 31-504 | 100.0 | 1×HEM; 1×U7P; |
|
| Human steroidogenic cytochrome P450 17A1 mutant A105L with substrate progesterone | | monomer | 31-504 | 99.78 | 1×HEM; 1×STR; |
|
| Human steroidogenic cytochrome P450 17A1 mutant A105L with substrate 17alpha-hydroxypregnenolone | | monomer | 31-504 | 99.78 | 1×HEM; 1×LZZ; |
|
| Human cytochrome P450 17A1 bound to inhibitor VT-464 | | monomer | 31-504 | 100.0 | 1×HEM; 1×6D8; |
|
| Human steroidogenic cytochrome P450 17A1 mutant N52Y with inhibitor abiraterone | | monomer | 29-501 | 99.78 | 1×HEM; 1×AER; |
|
| Human steroidogenic cytochrome P450 17A1 with 3-keto-5alpha-abiraterone analog | | monomer | 31-503 | 100.0 | 1×HEM; 1×UDJ; |
|
| Human cytochrome P450 17A1 bound to inhibitors (R)- and (S)- orteronel | | monomer | 31-503 | 100.0 | 1×HEM; 1×6D7; |
|
| Human steroidogenic cytochrome P450 17A1 mutant A105L with substrate pregnenolone | | monomer | 31-503 | 99.78 | 1×HEM; 1×PLO; |
|
| Human steroidogenic cytochrome P450 17A1 mutant A105L with substrate 17alpha-hydroxyprogesterone | | monomer | 31-503 | 99.78 | 1×HEM; 1×3QZ; |
|
| Human Cytochrome P450 CYP17A1 in complex with Abiraterone | | monomer | 31-503 | 100.0 | 1×HEM; 1×AER; |
|
| Human steroidogenic cytochrome P450 17A1 mutant A105L with inhibitor abiraterone | | monomer | 31-503 | 99.78 | 1×HEM; 1×AER; |
|